TRACON Pharmaceuticals, Inc (TCON) - Cash per Single Share

Symbol and logo of brand TRACON Pharmaceuticals, Inc (TCON)

Strict adherence to FDA regulations limits the operational activities of TRACON Pharmaceuticals. Growth potential is driven by envafolimab developments and bioengineering IT solutions. The cash per share on this chart on GURU.Markets reflects liquidity dynamics, where the 0.00 mark captures the current state. Business stability is supported by partnership research into targeted antibodies for oncology.

TCON TRACON Pharmaceuticals, Inc.: Cash per Single Share in the range 07/04/2022 - 08/04/2024

Comprehensive metric breakdowns and analytics for TRACON Pharmaceuticals Inc. (TCON)

- price and consensus price forecast:
- cash and cash flow data:
Summary company analysis:TCON TRACON
Finished products of TRACON Pharmaceuticals, Inc.

The lack of proprietary manufacturing facilities and reliance on external contractors make TRACON Pharmaceuticals (TCON) highly dependent on liquidity. By analyzing cash per share, an investor can determine the actual value of the liquid collateral backing each security. This metric measures the burn rate of R&D reserves in an environment of expensive capital. The current trend in cash per share defines the horizon of financial autonomy, which serves as a key factor in assessing the company's market capitalization.

Key competitors

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share FDMT|Cash Funds per Single Share LXEO (Lexeo Therapeutics)|Cash per Share KRRO|Editas Medicine, Inc. - Cash Funds per Single Share|Cash Funds per Share Silence Therapeutics Inc. SLN|Cash per Share ProQR Therapeutics N.V. PRQR|CDXS: Cash per Single Share|Cash Funds Volume per Share Sangamo (SGMO)|NAUT (Nautilus Bio) - Cash per Single Share|MGX - Cash Funds Calculated per Share|DTIL (Precision BioSciences Inc.) - Cash per Share|generationbio.com (GBIO) - Cash Funds Calculated per Share|Cash Funds per Share Boundless Bio Inc (BOLD)|Cash per Share Exicure Inc. (XCUR)|Cash Funds per Share imunon.com IMNN|Cash per Share Phio Pharmaceuticals PHIO|Mustang Bio Inc - Cash per Share|Cash on Hand per Share transcodetherapeutics.com|BNGO: Cash per Share|Cash Funds per Single Share APDN|BLUE (bluebirdbio.com) - Cash per Share|Cash on Hand per Share ImmunoPrecise Antibodies IPA|Cash per Single Share OMGA (omegatherapeutics.com)|Cash per Share Singular Genomics Systems, Inc. (OMIC)|Cash per Share RGLS (Regulus Therapeutics, Inc.)|Cash per Share Syros SYRS|Telesis Bio, Inc. - Cash per Share|Cash on Hand per Share Unity Biotechnology